What is happening at Pivot Park?

News

Categories

News

Eerste studenten lectoraat Drug Discovery in september op Pivot Park

Het lectoraat Drug Discovery van de Academie Toegepaste Biowetenschappen en Chemie in Nijmegen start in september met zijn eerste studenten op het lab op Pivot Park. Het lectoraat maakt deel uit van de HAN University of Applied Sciences. We zitten in de kelder van het RE-gebouw (0201), een lab waar we zowel biologische als chemische onderwerpen kunnen adresseren en waar ongeveer 10 tot 15 studenten tegelijk kunnen werken.

Read More »
News

Welkom Van Iersel Luchtman Advocaten

Vanaf mei 2021 is ons advocatenkantoor aangesloten bij het Pivot Park. Als satellite tenant hebben we geen vast kantoor, maar zijn we altijd bereikbaar en beschikbaar om je (virtueel) te ontmoeten als daar behoefte aan is.

Read More »
News

Ardena’s success leads to major €35 million investment for expansion in Belgium, Sweden and The Netherlands

In partnership with GHO Capital, ARDENA announced a major €35 million investment for expansion across its European operations. The investment will future proof offerings for the biopharma and emerging biotechnology sectors and positions Ardena to become a leading global CDMO, offering end-to-end solutions spanning the full pharma development lifecycle.

Read More »
News

Inprocess-lsp and DIANT Pharma Inc. finalize Partnership Agreement

DIANT Continuous Nanoparticle Manufacturing System Integrates With InProcess-LSP NanoFlowSizer For Size Characterization.

DIANT Pharma Inc. (DIANT), a startup company that provides a turnkey solution for continuous manufacturing of nanoparticles, has the exclusive right to integrate the NanoFlowSizer into the DIANT system, providing a major advantage to DIANT customers. The DIANT system has multiple flow options, up to 100 LPM, and has multiple add-on modules with integrated process analytical technology operating as a single, closed-system.

Read More »
News

Aspen evacuation signal test on July 7th

Aspen will test the evacuation signal on TTP (Tanker truckpark) on Wednesday July 7th. This evacuation signal will sound for a few seconds each time, so that the nuisance for the environment is as minimal as possible. The evacuation signal will be heard within times on Wednesday 7 July:
Between 9 a.m. and 10 a.m. and between 2 pm and 4 pm.

Read More »

#100YEARSPHARMAFUTURE

The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.